Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease

scientific article published on 01 May 1995

Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0021-9150(94)05498-8
P698PubMed publication ID7669086

P2093author name stringF B Smith
A J Lee
A Rumley
F G Fowkes
G D Lowe
P433issue1
P921main subjectplasminogenQ107129060
P304page(s)35-43
P577publication date1995-05-01
P1433published inAtherosclerosisQ4813570
P1476titleTissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease
P478volume115

Reverse relations

cites work (P2860)
Q87411732Age and aerobic training status effects on plasma and skeletal muscle tPA and PAI-1
Q47764147Biologic markers as predictors of cardiovascular disease
Q73025879Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta
Q41559774Epidemiology of peripheral vascular disease
Q35213428Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease
Q28658007Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
Q53345237Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators.
Q22252221Obesity and Thrombosis
Q34384926Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease
Q34376916Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.

Search more.